COV2008
This study is investigating the safety and efficacy of the Johnson & Johnson Adv.26 booster vaccine in healthy adults who have previously received the Pfizer COVID-19 vaccine. This study is currently enrolling participants.
This study is investigating the safety and efficacy of the Johnson & Johnson Adv.26 booster vaccine in healthy adults who have previously received the Pfizer COVID-19 vaccine. This study is currently enrolling participants.
This study is assessing antibodies for the prevention of SARS CoV-2 infection of asymptomatic healthy adults.
This study is assessing two different dosages of an investigational COVID-19 vaccine in healthy adults. This trial completed enrollment in August 2020 and is ongoing.
This study is evaluating different vaccine regimens using experimental HIV vaccines in healthy HIV-negative adults. The study finished enrollment in September 2017 and is ongoing.
This study assessed two different dosages of an investigational Zika Virus vaccine in healthy adults. The study closed enrollment in September 2018. Data analysis is underway.
This study assessed different dosages of a monoclonal antibody in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018.
This study evaluated different dosages of a monoclonal antibody given in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018.
This study is assessing the use of an infusion of three antibodies as an alternative treatment for people living with HIV.
This study is assessing a therapeutic HIV vaccine as an alternative treatment for people living with HIV. This trial completed enrollment in January 2020 and is ongoing.
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu